Most drugs which humans abuse serve as positive reinforcers to maintain and strengthen behavior leading to their administration in animals. Experiments are being conducted to assess behavior maintained by psychoactive drugs in rats and monkeys and the ability of pharmacological or behavioral manipulations to modify drug-seeking and drug-taking behavior. Currently, studies are focusing on cocaine, methamphetamine, nicotine, and delta-9-THC (active ingredient of marijuana) using various experimental procedures, including; intravenous self-administration to assess reinforcing efficacy, radioligand binding and quantitative autoradiography to measure density of D1, D2, mu-opioid, 5-HT and DA uptake sites in several brain regions after persistent methamphetamine or cocaine self-administration, and assessment of the effectiveness of different serotonergic or dopaminergic agonists and antagonists in attenuating methamphetamine's or cocaine's reinforcing properties. In one study, possible differences in reinforcing and neuroadaptive responses to cocaine versus GBR-12909, a selective inhibitor of the DA transporter with a postulated therapeutic use in cocaine abuse, were evaluated. Cocaine and GBR-12909 differentially affected dopaminergic systems and had different reinforcing and neuroadaptive effects. In other studies, we are examining effects of caffeine exposure on reinforcing and other behavioral properties of nicotine. Rats consuming caffeine in their drinking water acquired i.v. nicotine self-administration faster and reached higher levels of intake than controls. Squirrel monkeys showed increases in nicotine self-administration responding and a marked potentiation of other behavioral effects of nicotine. Finally, research in our lab has shown that rats and monkeys will emit long chains of behavior under second-order schedules to obtain highly infrequent or even single injections of drug. Currently, second-order schedules are being used to study motivational properties of stimuli associated with cocaine or methamphetamine self-administration in rats and squirrel monkeys, to try to develop an animal model of marijuana abuse in monkeys, and to assess underlying neurobiological mechanisms. Since second-order schedules are more analogous to the human drug abuse situation, the study of pharmacological and behavioral means of reducing behavior maintained using these procedures will have important implications for prevention of HIV transmission related to drug abuse.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Intramural Research (Z01)
Project #
1Z01DA000001-12
Application #
2571587
Study Section
Special Emphasis Panel (PP)
Project Start
Project End
Budget Start
Budget End
Support Year
12
Fiscal Year
1996
Total Cost
Indirect Cost
Name
National Institute on Drug Abuse
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Adell, Manuel Alonso Y; Teis, David (2011) Assembly and disassembly of the ESCRT-III membrane scission complex. FEBS Lett 585:3191-6
Le Foll, Bernard; Chefer, Svetlana I; Kimes, Alane S et al. (2009) Baseline expression of alpha4beta2* nicotinic acetylcholine receptors predicts motivation to self-administer nicotine. Biol Psychiatry 65:714-6
Ferré, Sergi; Goldberg, Steven R; Lluis, Carme et al. (2009) Looking for the role of cannabinoid receptor heteromers in striatal function. Neuropharmacology 56 Suppl 1:226-34
Justinova, Zuzana; Munzar, Patrik; Panlilio, Leigh V et al. (2008) Blockade of THC-seeking behavior and relapse in monkeys by the cannabinoid CB(1)-receptor antagonist rimonabant. Neuropsychopharmacology 33:2870-7
Panlilio, Leigh V; Thorndike, Eric B; Schindler, Charles W (2008) A stimulus-control account of regulated drug intake in rats. Psychopharmacology (Berl) 196:441-50
Le Foll, Bernard; Forget, Benoit; Aubin, Henri-Jean et al. (2008) Blocking cannabinoid CB1 receptors for the treatment of nicotine dependence: insights from pre-clinical and clinical studies. Addict Biol 13:239-52
Marcellino, Daniel; Ferre, Sergi; Casado, Vicent et al. (2008) Identification of dopamine D1-D3 receptor heteromers. Indications for a role of synergistic D1-D3 receptor interactions in the striatum. J Biol Chem 283:26016-25
Scherma, Maria; Medalie, Julie; Fratta, Walter et al. (2008) The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition. Neuropharmacology 54:129-40
Le Foll, Bernard; Wertheim, Carrie; Goldberg, Steven R (2007) High reinforcing efficacy of nicotine in non-human primates. PLoS ONE 2:e230
Solinas, Marcello; Scherma, Maria; Fattore, Liana et al. (2007) Nicotinic alpha 7 receptors as a new target for treatment of cannabis abuse. J Neurosci 27:5615-20

Showing the most recent 10 out of 71 publications